{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T08:40:09Z","timestamp":1778402409261,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.nbd.2013.02.010","type":"journal-article","created":{"date-parts":[[2013,3,4]],"date-time":"2013-03-04T22:33:53Z","timestamp":1362436433000},"page":"32-42","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["PACAP signaling exerts opposing effects on neuroprotection and neuroinflammation during disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis"],"prefix":"10.1016","volume":"54","author":[{"given":"Cornelia","family":"Ringer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa-Sybille","family":"B\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin K.H.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee E.","family":"Eiden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberhard","family":"Weihe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burkhard","family":"Sch\u00fctz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2013.02.010_bb0005","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1007622107","article-title":"Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis","volume":"107","author":"Abad","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.02.010_bb0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.it.2009.09.003","article-title":"T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?","volume":"31","author":"Appel","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0015","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/endo-129-5-2787","article-title":"Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes","volume":"129","author":"Arimura","year":"1991","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2013.02.010_bb0020","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jnr.10750","article-title":"Lymphocyte regulation of neuropeptide gene expression after neuronal injury","volume":"74","author":"Armstrong","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2013.02.010_bb0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroscience.2007.09.084","article-title":"Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide","volume":"151","author":"Armstrong","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2013.02.010_bb0030","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.wco.0000183114.76056.0e","article-title":"Autonomic impairment in amyotrophic lateral sclerosis","volume":"18","author":"Baltadzhieva","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0035","doi-asserted-by":"crossref","first-page":"16021","DOI":"10.1073\/pnas.0607423103","article-title":"Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis","volume":"103","author":"Beers","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.02.010_bb0040","doi-asserted-by":"crossref","first-page":"15558","DOI":"10.1073\/pnas.0807419105","article-title":"CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS","volume":"105","author":"Beers","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.02.010_bb0045","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/187152710791292576","article-title":"Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target","volume":"9","author":"Bogaert","year":"2010","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.nbd.2013.02.010_bb0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuron.2006.09.018","article-title":"ALS: a disease of motor neurons and their nonneuronal neighbors","volume":"52","author":"Boill\u00e9e","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2013.02.010_bb0055","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s12031-008-9073-7","article-title":"The N-terminal parts of VIP and antagonist PG97-269 physically interact with different regions of the human VPAC1 receptor","volume":"36","author":"Ceraudo","year":"2008","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0060","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neulet.2005.04.070","article-title":"Pituitary adenylate cyclase-activating polypeptide prevents cell death in the spinal cord with traumatic injury","volume":"384","author":"Chen","year":"2005","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2013.02.010_bb0065","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.regpep.2006.06.016","article-title":"Neuroprotection by endogenous and exogenous PACAP following stroke","volume":"137","author":"Chen","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.nbd.2013.02.010_bb0070","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1126\/science.1086071","article-title":"Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice","volume":"302","author":"Clement","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.02.010_bb0075","first-page":"307","article-title":"Neuroprotective potential of three neuropeptides PACAP, VIP and PHI","volume":"57","author":"Dejda","year":"2005","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.nbd.2013.02.010_bb0080","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.peptides.2011.04.003","article-title":"PACAP and a novel stable analog protect rat brain from ischemia: insight into the mechanisms of action","volume":"32","author":"Dejda","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2013.02.010_bb0085","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/glia.10098","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia","volume":"39","author":"Delgado","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2013.02.010_bb0090","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1189\/jlb.0702372","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia","volume":"73","author":"Delgado","year":"2003","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0095","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pharmthera.2008.11.006","article-title":"VPAC and PAC receptors: from ligands to function","volume":"121","author":"Dickson","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.nbd.2013.02.010_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1474-4422(10)70224-6","article-title":"Energy metabolism in amyotrophic lateral sclerosis","volume":"10","author":"Dupuis","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.peptides.2004.01.010","article-title":"Neurotransmitters co-existing with VIP or PACAP","volume":"25","author":"Fahrenkrug","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2013.02.010_bb0110","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/NEN.0b013e3181f4dcef","article-title":"Downregulation of the potassium chloride cotransporter KCC2 in vulnerable motoneurons in the SOD1-G93A mouse model of amyotrophic lateral sclerosis","volume":"69","author":"Fuchs","year":"2010","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0115","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1096\/fj.11-182337","article-title":"The VPAC2 agonist peptide histidine isoleucine (PHI) up-regulates glutamate transport in the corpus callosum of a rat model of amyotrophic lateral sclerosis (hSOD1G93A) by inhibiting caspase-3 mediated inactivation of GLT-1a","volume":"25","author":"Goursaud","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2013.02.010_bb0120","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1046\/j.1460-9568.1999.00693.x","article-title":"Functional and molecular diversity of PACAP\/VIP receptors in cortical neurons and type I astrocytes","volume":"11","author":"Grimaldi","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0125","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.nbd.2013.02.010_bb0130","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0304-3940(02)01140-0","article-title":"Differential vulnerability of cranial motoneurons in mouse models with motor neuron degeneration","volume":"335","author":"Haenggeli","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2013.02.010_bb0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1073\/pnas.012608999","article-title":"Pituitary adenylate cyclase-activating polypeptide is a sympathoadrenal neurotransmitter involved in catecholamine regulation and glucohomeostasis","volume":"99","author":"Hamelink","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.02.010_bb0140","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cne.10418","article-title":"Pituitary adenylate cyclase-activating peptide in the rat central nervous system: an immunohistochemical and in situ hybridization study","volume":"453","author":"Hannibal","year":"2002","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0145","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jneumeth.2005.10.023","article-title":"A low-cost solution to measure mouse licking in an electrophysiological setup with a standard analog-to-digital converter","volume":"153","author":"Hayar","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.nbd.2013.02.010_bb0150","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11481-009-9171-5","article-title":"Microglia in ALS: the good, the bad, and the resting","volume":"4","author":"Henkel","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0155","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1083\/jcb.200908164","article-title":"Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond","volume":"187","author":"Ilieva","year":"2009","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0160","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.autneu.2010.09.002","article-title":"Autonomic impairment in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"159","author":"Kandinov","year":"2011","journal-title":"Auton. Neurosci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0165","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/17482968.2012.662986","article-title":"Blood pressure measurements in a transgenic SOD1-G93A mouse model of amyotrophic lateral sclerosis","volume":"13","author":"Kandinov","year":"2012","journal-title":"Amyotroph. Lateral Scler."},{"key":"10.1016\/j.nbd.2013.02.010_bb0170","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","article-title":"Amyotrophic lateral sclerosis","volume":"377","author":"Kiernan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2013.02.010_bb0175","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1523\/JNEUROSCI.20-10-03622.2000","article-title":"Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway","volume":"20","author":"Kim","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0180","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0165-5728(02)00059-0","article-title":"Inhibition of microglial CD40 expression by pituitary adenylate cyclase-activating polypeptide is mediated by interleukin-10","volume":"126","author":"Kim","year":"2002","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0185","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1523\/JNEUROSCI.18-09-03241.1998","article-title":"Massive mitochondrial degeneration in motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1","volume":"18","author":"Kong","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0190","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.peptides.2007.04.026","article-title":"Class II G protein-coupled receptors for VIP and PACAP: structure, models of activation and pharmacology","volume":"28","author":"Laburthe","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2013.02.010_bb0195","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1749-6632.2000.tb06954.x","article-title":"Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP","volume":"921","author":"Leceta","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0200","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.peptides.2007.06.021","article-title":"Maxadilan, a PAC1 receptor agonist from sand flies","volume":"28","author":"Lerner","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2013.02.010_bb0205","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jchemneu.2009.06.001","article-title":"Anatomy of synaptic circuits controlling the activity of sympathetic preganglionic neurons","volume":"38","author":"Llewellyn-Smith","year":"2009","journal-title":"J. Chem. Neuroanat."},{"key":"10.1016\/j.nbd.2013.02.010_bb0210","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.peptides.2007.05.005","article-title":"PACAP and PDF signaling in the regulation of mammalian and insect circadian rhythms","volume":"28","author":"Mertens","year":"2007","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2013.02.010_bb0215","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1002\/cne.22718","article-title":"Differential gene expression in the axotomized facial motor nucleus of presymptomatic SOD1 mice","volume":"519","author":"Mesnard","year":"2011","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0220","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0006-291X(89)91757-9","article-title":"Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells","volume":"164","author":"Miyata","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2013.02.010_bb0225","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0006-291X(90)92140-U","article-title":"Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38)","volume":"170","author":"Miyata","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2013.02.010_bb0230","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.bbadis.2006.03.001","article-title":"Innate immunity in amyotrophic lateral sclerosis","volume":"1762","author":"Moisse","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2013.02.010_bb0235","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0006-8993(97)00923-2","article-title":"The effects of axotomy and preganglionic denervation on the expression of pituitary adenylate cyclase activating peptide (PACAP), galanin and PACAP type 1 receptors in the rat superior cervical ganglion","volume":"775","author":"Moller","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2013.02.010_bb0240","doi-asserted-by":"crossref","first-page":"7488","DOI":"10.1073\/pnas.0600375103","article-title":"Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6","volume":"103","author":"Ohtaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.02.010_bb0245","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/BF00230482","article-title":"Oculomotor nuclear pathology in amyotrophic lateral sclerosis","volume":"85","author":"Okamoto","year":"1993","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0250","doi-asserted-by":"crossref","first-page":"17803","DOI":"10.1073\/pnas.1103141108","article-title":"Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo","volume":"108","author":"Papadeas","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.02.010_bb0255","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cne.20015","article-title":"PACAP mRNA is expressed in rat spinal cord neurons","volume":"471","author":"Pettersson","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0260","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1474-4422(11)70015-1","article-title":"Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease","volume":"10","author":"Philips","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0265","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1096\/fj.10-180133","article-title":"Neuropeptide pituitary adenylate cyclase-activating polypeptide (PACAP) slows down Alzheimer's disease-like pathology in amyloid precursor protein-transgenic mice","volume":"25","author":"Rat","year":"2011","journal-title":"FASEB J."},{"key":"10.1016\/j.nbd.2013.02.010_bb0270","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/S0196-9781(02)00262-0","article-title":"Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia","volume":"23","author":"Reglodi","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2013.02.010_bb0275","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.regpep.2004.05.016","article-title":"Morphological and functional effects of PACAP in 6-hydroxydopamine-induced lesion of the substantia nigra in rats","volume":"123","author":"Reglodi","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.nbd.2013.02.010_bb0280","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1196\/annals.1317.072","article-title":"Comparative study of the effects of PACAP in young, aging, and castrated males in a rat model of Parkinson's disease","volume":"1070","author":"Regl\u00f3di","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0285","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s12031-012-9762-0","article-title":"PACAP is an endogenous protective factor-insights from PACAP-deficient mice","volume":"48","author":"Reglodi","year":"2012","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0290","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nbd.2009.05.011","article-title":"Pre-symptomatic alterations in subcellular betaCGRP distribution in motor neurons precede astrogliosis in ALS mice","volume":"35","author":"Ringer","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.02.010_bb0295","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.nbd.2011.09.011","article-title":"Calcitonin gene-related peptide expression levels predict motor neuron vulnerability in the superoxide dismutase 1-G93A mouse model of amyotrophic lateral sclerosis","volume":"45","author":"Ringer","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2013.02.010_bb0300","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2013.02.010_bb0305","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.21543","article-title":"Current hypotheses for the underlying biology of amyotrophic lateral sclerosis","volume":"65","author":"Rothstein","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0310","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1523\/JNEUROSCI.2038-05.2005","article-title":"The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice","volume":"25","author":"Sch\u00fctz","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0315","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2174\/138161211795049679","article-title":"Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis","volume":"17","author":"Seaborn","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.nbd.2013.02.010_bb0320","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1196\/annals.1317.080","article-title":"Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment","volume":"1070","author":"Shioda","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.nbd.2013.02.010_bb0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/glia.10154","article-title":"Microglia as neuroprotective, immunocompetent cells of the CNS","volume":"40","author":"Streit","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2013.02.010_bb0330","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11481-009-9163-5","article-title":"Life and death of microglia","volume":"4","author":"Streit","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0335","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1365-2826.2011.02202.x","article-title":"Pituitary adenylate cyclase-activating polypeptide controls stimulus-transcription coupling in the hypothalamic-pituitary\u2013adrenal axis to mediate sustained hormone secretion during stress","volume":"23","author":"Stroth","year":"2011","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.nbd.2013.02.010_bb0340","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1073\/pnas.0812257106","article-title":"Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis","volume":"106","author":"Tan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2013.02.010_bb0345","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1471-4159.2008.05638.x","article-title":"Survival-promoting activity of pituitary adenylate cyclase-activating polypeptide in the presence of phosphodiesterase inhibitors on rat motoneurons in culture: cAMP-protein kinase A-mediated survival","volume":"107","author":"Tomimatsu","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2013.02.010_bb0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.npep.2008.03.002","article-title":"Neuroprotective effects of PACAP27 in mice model of Parkinson's disease involved in the modulation of K(ATP) subunits and D2 receptors in the striatum","volume":"42","author":"Wang","year":"2008","journal-title":"Neuropeptides"},{"key":"10.1016\/j.nbd.2013.02.010_bb0355","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/glia.20062","article-title":"Increased cytotoxic potential of microglia from ALS-transgenic mice","volume":"48","author":"Weydt","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2013.02.010_bb0360","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0304-3940(96)12516-7","article-title":"The effect of pituitary adenylate cyclase activating peptide (PACAP) on the nociceptive formalin test","volume":"207","author":"Zhang","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2013.02.010_bb0365","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/(SICI)1097-4547(19990915)57:6<953::AID-JNR21>3.0.CO;2-R","article-title":"Axotomy-induced changes in pituitary adenylate cyclase activating polypeptide (PACAP) and PACAP receptor gene expression in the adult rat facial motor nucleus","volume":"57","author":"Zhou","year":"1999","journal-title":"J. Neurosci. Res."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113000727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996113000727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T11:39:36Z","timestamp":1562758776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996113000727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":73,"alternative-id":["S0969996113000727"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2013.02.010","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}